Video Experimental Relacionado
Updated: Feb 2, 2026
09:20
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
1.3K
Firmas transcriptómicas específicas del fenotipo radiológico en tejidos pulmonares de pacientes con enfermedad
Ju Mi Lee1, Su-Young Kim2, Seong Mi Moon3
1Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Yonsei University College of Medicine, Brain Korea 21 Project, Seoul, South Korea.
European journal of medical research
|January 31, 2026
Resumen
Los investigadores identificaron distintos patrones de expresión génica en diferentes formas de enfermedad pulmonar (EP) por Mycobacterium avium (MAC). Estos biomarcadores transcriptómicos podrían ayudar en el diagnóstico temprano y el tratamiento personalizado para pacientes con MAC-EP.
Área de la Ciencia:
- Medicina Pulmonar
- Genómica
- Inmunología
Sus antecedentes:
- La incidencia de la enfermedad pulmonar por Mycobacterium avium complex (MAC) está aumentando, lo que presenta desafíos diagnósticos y terapéuticos.
- Las pautas actuales implican el monitoreo serial por TC, con respuestas variables al tratamiento entre las formas nodular bronquiectásica (NB) y fibrocavernosa (FC).
- Se necesitan biomarcadores específicos del fenotipo para mejorar el diagnóstico temprano y las estrategias de tratamiento personalizadas.
Objetivo del estudio:
- Identificar diferencias transcriptómicas entre las formas NB y FC de la enfermedad pulmonar por MAC.
- Explorar posibles biomarcadores diagnósticos para fenotipos de MAC-EP.
- Sentar las bases para diagnósticos de precisión en MAC-EP.
Principales métodos:
- Se analizaron tejidos pulmonares pareados resecados quirúrgicamente de 21 pacientes con MAC-EP (11 NB, 10 FC) utilizando secuenciación de ARN cuantitativa.
- Se realizaron análisis bioinformáticos, incluidas redes de Ontología Génica (GO) y de Interacción Proteína-Proteína (PPI).
- Las firmas transcriptómicas se correlacionaron con los fenotipos radiológicos.
Principales resultados:
- Se identificaron firmas transcriptómicas distintas y compartidas entre los fenotipos NB y FC.
- Ambas formas mostraron clústeres de genes significativos relacionados con la proliferación de células B y la regulación inmune.
- Las firmas específicas de NB involucraron respuestas inmunes antimicrobianas, mientras que las firmas específicas de FC se vincularon con la remodelación de la matriz extracelular.
Conclusiones:
- Este estudio proporciona la primera caracterización de las diferencias transcriptómicas entre fenotipos de MAC-EP utilizando tejidos pulmonares pareados.
- Los marcadores transcriptómicos identificados muestran un valor diagnóstico potencial correlacionado con subtipos radiológicos.
- Se requieren validaciones adicionales en cohortes más grandes y ensayos funcionales para la aplicación clínica.
Palabras clave:
Enfermedad pulmonar por complejo Mycobacterium aviumFenotipos radiológicosPerfil transcriptómicofibrocavernosobronquiectásico nodularMás Videos Relacionados
Videos de Conceptos Relacionados
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
473
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
473
01:47Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K